RGLJX | RWICX | RGLJX / RWICX | |
Total Expense Ratio | 0.60 | 1.06 | 57% |
Annual Report Gross Expense Ratio | 0.67 | 1.06 | 63% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 9.850 | 8.879 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.8B | 131B | 13% |
Annual Yield % from dividends | 1.04 | 1.26 | 82% |
Returns for 1 year | 12.55 | 5.98 | 210% |
Returns for 3 years | 52.69 | 42.88 | 123% |
Returns for 5 years | 67.15 | 50.18 | 134% |
Returns for 10 years | N/A | 50.31 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SABA | 9.04 | 0.05 | +0.56% |
Saba Capital Income & Opportunities Fund II | |||
IXJ | 87.81 | -0.87 | -0.98% |
iShares Global Healthcare ETF | |||
PICK | 37.44 | -0.45 | -1.19% |
iShares MSCI Global Mtls&Mng Prdcrs ETF | |||
CGGE | 28.27 | -0.37 | -1.29% |
Capital Group Global Equity ETF | |||
IZRL | 24.25 | -0.36 | -1.46% |
ARK Israel Innovative Technology ETF |